PAD and CLI economics: where the procedural revenue actually flows
Peripheral arterial and critical limb ischemia procedures have unique economics. Here’s the rate data and operator considerations.
Tag: physician finance
AI dictation and procedural tools for vascular surgery
Vascular AI is moving toward procedural dictation, coding, and case prep. Here’s the working stack.
Real estate for vascular surgeons
Vascular surgery income supports aggressive real estate. Here’s the playbook.
Tax planning for vascular surgeons with OBL equity
Vascular K-1 from endovascular OBL shields differently than W-2. Here’s the optimization stack.
Endovascular OBL ownership: the new ASC frontier for vascular surgeons
Endovascular labs are migrating outpatient — same procedural revenue, lower overhead, owner-equity. Here’s the modeling.
AI tools for urology
Urology AI is moving toward MRI fusion biopsy, robotics, and pathology. Here’s the directory.
Prostate cancer pathway economics
Urology owns the prostate cancer chain — biopsy, MRI, treatment selection. Here’s how to capture the economics.
Real estate for urologists
Urology income supports aggressive real estate. Here’s the playbook.
Tax planning for urologists with ASC + practice equity
Urology K-1 from practice + ASC + lithotripsy is a complex income mix. Here’s the tax structure.
ASC urology + service line economics
Urology has one of the densest service-line economics in medicine — surgery, robotics, in-office, lithotripsy. Here’s the modeling.